Overview

Clinical Trial Expert Forum is a technical discussion group comprising of Senior Clinical Trial Team Leaders and/or R & D Heads. The forum envisages bringing together both the Sponsor and the CRO companies at a single platform to discuss the hottest issues and topics for achieving research and business objectives. The objective of this Clinical Trial Expert Forum is to discuss the bottlenecks and their solutions for conducting successful clinical studies.

Today we are living in the digital world and there has been a substantial impact of digitalization on the clinical trial process in the recent years. Digitalization in clinical studies involves leveraging digital technology to improve participant access, engagement, trial-related measurements, and/or interventions, enable concealed randomized intervention allocation, and has the potential to transform clinical trials and to lower their cost. The complex protocols and pandemic restrictions have greatly affected the smooth conduct of the clinical trials. Patient recruitment is nowadays one of the biggest risks to completing studies while following the strict timelines. Moreover, virtual meetings have become a new normal.

Awareness of new challenges, strategic planning in the current and altered scenario is of utmost importance now, in order to optimize and facilitate the efficient clinical trial process. Therefore, it is equally necessary for both the CRO and Sponsor organizations involved in clinical studies to understand and follow the new rules and opportunities of the digital world. Looking into the current requirement and extensive pressure on both CRO and Sponsors, this Clinical Trial Discussion Forum is being organized on September 2-3, 2021, virtually. The Experts of this forum will deliberate on the current problems related to the topic, limitations, and their proposed solutions in all aspects of clinical trials i.e. Virtual Meetings & Trial Monitoring, Outsourcing Risks and Management, Patient Recruitment, Retention & Engagement and Clinical Trial Design & Data.

The H2L Concept- The H2L or Honing to Lead is a novel concept and means honing or refining skills of the team leaders who have the responsibility to steer their team towards achieving the organizational goals. The H2L concept is about refining specifically the technical skills of the team leaders through higher level experts who have vast first-hand experience in the respective areas so that the leader gets an extremely focused conceptual insight into the problem area. This essentially involves bringing together the leaders who share a common platform with the Experts and where the Experts develop an atmosphere conducive to open discussion rather than a regular speaking-listening session.

Who Should Attend: Heads, Vice Presidents, Directors, Senior Managers, Team Leaders, Senior Scientists from Sponsor/Pharma and CRO/Clinical Trials Organizations working in various domains: Formulation Development, Regulatory Affairs, Clinical trials, Quality Control, Quality Assurance, Investigator Site Management, Outsourcing Management, Auditors, Clinical Research and Development, IT & Data management, Pharmacovigilance, Medical Affairs, R&D and Strategic issues, Business Development, etc.

Contacts

Technical Query: Ms. Pooja Sharma, M: 7696325050, Email: p.sharma@glostem.com
Participation Query: Ms. Swati Kanwar, M: 8289015050, Email: s.kanwar@glostem.com and Ms Ankita Kanwar, M:7696425050, Email: ankita@glostem.com